Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
A unique cell-mediated cytotoxicity assay, which can be used for longitudinal patient studies, is described. A study of a patient with renal cell carcinoma is presented.
D000230:Adenocarcinoma / Q000276:immunology*; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D003601:Cytotoxicity Tests, Immunologic / Q000379:methods*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D007680:Kidney Neoplasms / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology*; D014565:Urogenital Neoplasms / Q000276:immunology